CTOs on the Move

Sobi North America

www.sobi-northamerica.com

 
Sobi is an international specialty healthcare company dedicated to developing treatments and extensive patient support networks for people with rare and difficult to treat diseases. These patients are often misunderstood, misdiagnosed and have limited medical options otherwise. This commitment has led to our world-class capabilities in protein biochemistry and biologics manufacturing, recognized by our leading industry partners.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Douglas County Hospital

Douglas County Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Alexandria, MN. To find more information about Douglas County Hospital, please visit www.dchospital.com

Greenway Health

Improving health is at the heart of Greenway Health`s work. We connect providers to the right information and insights, at the right place and time, so they can make patient-driven care a reality while navigating the ever-changing healthcare system. Greenway delivers exceptional service through a deep team of clinical, financial, and technology experts committed to innovations that keep people healthier and happier. We partner with over 8,000 organizations and 75,000 progressive providers across more than 40 specialties, which translates into more than 100 million lives that are touched by our solutions. All of Greenway Health`s solutions and services are designed to meet our company-wide goals of serving physicians, connecting the industry, and empowering better care. Whether as a customer, strategic partner, or staff member, you are invited to partner with us to create a smarter healthcare system.

Gilda'S Club

Gilda'S Club is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

International Biometric Group

International Biometric Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.